Publicaciones en colaboración con investigadores/as de Universitat Autònoma de Barcelona (14)

2023

  1. Prevalence of treated patients with Alzheimer’s disease: current trends and COVID-19 impact

    Alzheimer's Research and Therapy, Vol. 15, Núm. 1

2022

  1. Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer's disease

    Molecular neurodegeneration, Vol. 17, Núm. 1, pp. 27

  2. Correction: Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer’s disease (Molecular Neurodegeneration, (2022), 17, 1, (27), 10.1186/s13024-022-00521-3)

    Molecular Neurodegeneration

2021

  1. Csf proteomic alzheimer’s disease-predictive subtypes in cognitively intact amyloid negative individuals

    Proteomes, Vol. 9, Núm. 3

  2. Long runs of homozygosity are associated with Alzheimer’s disease

    Translational Psychiatry, Vol. 11, Núm. 1

2020

  1. Pathophysiological subtypes of Alzheimer's disease based on cerebrospinal fluid proteomics

    Brain, Vol. 143, Núm. 12, pp. 3776-3792

2019

  1. Changes in synaptic proteins precede neurodegeneration markers in preclinical Alzheimer’s disease cerebrospinal fluid*

    Molecular and Cellular Proteomics, Vol. 18, Núm. 3, pp. 546-560

  2. Genome-wide association analysis of dementia and its clinical endophenotypes reveal novel loci associated with Alzheimer's disease and three causality networks: The GR@ACE project

    Alzheimer's and Dementia, Vol. 15, Núm. 10, pp. 1333-1347

2018

  1. Cortical microstructural changes along the Alzheimer's disease continuum

    Alzheimer's and Dementia, Vol. 14, Núm. 3, pp. 340-351

2017

  1. Cerebrospinal fluid mitochondrial DNA in the Alzheimer's disease continuum

    Neurobiology of Aging, Vol. 53, pp. 192.e1-192.e4

2015

  1. Amyloid precursor protein metabolism and inflammation markers in preclinical Alzheimer disease

    Neurology, Vol. 85, Núm. 7, pp. 626-633

2014

  1. Feasibility of lumbar puncture in the study of cerebrospinal fluid biomarkers for Alzheimer's disease: A multicenter study in Spain

    Journal of Alzheimer's Disease, Vol. 39, Núm. 4, pp. 719-726

2013

  1. Genetic risk score predicting accelerated progression from mild cognitive impairment to Alzheimer's disease

    Journal of Neural Transmission, Vol. 120, Núm. 5, pp. 807-812

2012

  1. Progression of Alzheimer disease in Europe: Data from the European ICTUS study

    Current Alzheimer Research, Vol. 9, Núm. 8, pp. 902-912